Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Decision making and management of gliomas: practical considerationsA F Hottinger, K Homicsko, L Negretti, et al.
Cancer Treatment Reviews|October 16, 2021
Turning tumors from cold to inflamed to improve immunotherapy responseC L Gerard, J Delyon, A Wicky, et al.
Cardiovascular and Interventional Radiology|September 14, 2018
Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic ApproachesA Digklia, R Duran, K Homicsko, et al.
Revue Medicale Suisse|July 9, 2015
[New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities]B Moura, K Homicsko, G Berthod, et al.
Revue Medicale Suisse|July 5, 2011
[Melanoma: a new therapeutic era]G Berthod, K Homicsko, H Bouchaab, et al.
Human Gene Therapy|August 20, 2008
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirusM Bazan-Peregrino, R C Carlisle, R Hernandez-Alcoceba, et al.
Biomedical Optics Express|May 28, 2016
Compact solid-state CMOS single-photon detector array for in vivo NIR fluorescence lifetime oncology measurementsH A R Homulle, F Powolny, P L Stegehuis, et al.
ESMO Open|October 30, 2025
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)K-L Koster, I Colombo, S Hayoz, et al.
Investigational New Drugs|March 21, 2017
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumorsA Stathis, D Hess, R von Moos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2023
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinomaN Gavrielatou, E Fortis, A Spathis, et al.
Pageof 2